Article Figures & Data
Figures
- Figure 1.
ECHO/THRIVE Outcomes.
Reproduced with permission from The Lancet. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Molina JM et al. July 16, 2011;378(9787)238–246.
- Figure 2.
Virological and Immunological Outcomes.
Reproduced with permission from JE Gallant, MD, MPH.
Tools
Table of contents
Cited By...
- No citing articles found.